Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1440
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia ; day:20 ; month:4 ; year:2017 ; pages:1-9
Journal of molecular medicine ; (20.4.2017), 1-9
- Keyword
-
Krebs
Onkologie
- Creator
-
Basilico, Silvia
- Contributor
-
Göttgens, Berthold
SpringerLink (Online service)
- DOI
-
10.1007/s00109-017-1535-3
- URN
-
urn:nbn:de:1111-201705055795
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Basilico, Silvia
- Göttgens, Berthold
- SpringerLink (Online service)
Other Objects (12)
Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space
Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Identification of CDX2 targets in acute myeloid leukaemia
Spontaneous chest wall haematoma in chronic myeloid leukaemia
Decreased MMP1 gene expression in acute myeloid leukaemia
Survival with chronic myeloid leukaemia after failing milestones
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation - immune signature correlates with response
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Treosulfan, Fludarabine and Cytarabine as a Conditioning Regimen for Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukaemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms
Single cell analysis of clonal architecture in acute myeloid leukaemia
Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space
Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Identification of CDX2 targets in acute myeloid leukaemia
Spontaneous chest wall haematoma in chronic myeloid leukaemia
Decreased MMP1 gene expression in acute myeloid leukaemia
Survival with chronic myeloid leukaemia after failing milestones
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation - immune signature correlates with response
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Treosulfan, Fludarabine and Cytarabine as a Conditioning Regimen for Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukaemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms
Single cell analysis of clonal architecture in acute myeloid leukaemia
Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space
Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Identification of CDX2 targets in acute myeloid leukaemia
Spontaneous chest wall haematoma in chronic myeloid leukaemia
Decreased MMP1 gene expression in acute myeloid leukaemia
Survival with chronic myeloid leukaemia after failing milestones
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation - immune signature correlates with response
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Treosulfan, Fludarabine and Cytarabine as a Conditioning Regimen for Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukaemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms